loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 52ef5879 4cb5 443a A355 5de14c497f22 Applno 207793 Form Injectable Liposomal Intravenous Dosage Eq 43mg Base 10ml Eq 4 3mg Base Ml - Drug Product Composition: 042LAQ1IIS

    Menu

    042LAQ1IIS

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 22,133Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 207793 / DOSAGE - INJECTABLE, LIPOSOMAL;INTRAVENOUS - EQ 43MG BASE/10ML (EQ 4.3MG BASE/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    IRINOTECAN HYDROCHLORIDE(UNII: 042LAQ1IIS)
    (IRINOTECAN - UNII:7673326042)     		IRINOTECAN HYDROCHLORIDE4.3mg in 1

    Inactive Ingredients

    Ingredient Name
    Merrimack Pharmaceuticals
    1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE(043IPI2M0K)
    CHOLESTEROL(97C5T2UQ7J)
    HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID(RWW266YE9I)
    SODIUM CHLORIDE(451W47IQ8X)
    SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(3L6NN8ZZKU)